Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they “feel good about the progress.” He speaks to Katie Greifeld.

Tigress's Ivan Feinseth Talks AI, Tech Stock IPOs
05:42

Marc Short Talks Latest US Peace Proposal to Iran War
06:33

JPMorgan Chase CEO Jamie Dimon Talks Bond Market, Inflation
23:01